These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31079989)

  • 1. Focused ultrasound-induced blood brain-barrier opening enhanced vascular permeability for GDNF delivery in Huntington's disease mouse model.
    Lin CY; Tsai CH; Feng LY; Chai WY; Lin CJ; Huang CY; Wei KC; Yeh CK; Chen CM; Liu HL
    Brain Stimul; 2019; 12(5):1143-1150. PubMed ID: 31079989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive, neuron-specific gene therapy by focused ultrasound-induced blood-brain barrier opening in Parkinson's disease mouse model.
    Lin CY; Hsieh HY; Chen CM; Wu SR; Tsai CH; Huang CY; Hua MY; Wei KC; Yeh CK; Liu HL
    J Control Release; 2016 Aug; 235():72-81. PubMed ID: 27235980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focused ultrasound-induced blood-brain barrier opening for non-viral, non-invasive, and targeted gene delivery.
    Lin CY; Hsieh HY; Pitt WG; Huang CY; Tseng IC; Yeh CK; Wei KC; Liu HL
    J Control Release; 2015 Aug; 212():1-9. PubMed ID: 26071631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease.
    Fan CH; Ting CY; Lin CY; Chan HL; Chang YC; Chen YY; Liu HL; Yeh CK
    Sci Rep; 2016 Jan; 6():19579. PubMed ID: 26786201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.
    Ebert AD; Barber AE; Heins BM; Svendsen CN
    Exp Neurol; 2010 Jul; 224(1):155-62. PubMed ID: 20227407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-responsive neurotrophic factor-loaded microbubble- liposome complex: Preclinical investigation for Parkinson's disease treatment.
    Lin CY; Lin YC; Huang CY; Wu SR; Chen CM; Liu HL
    J Control Release; 2020 May; 321():519-528. PubMed ID: 32112852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
    McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of GDNF through the blood-brain barrier by MRI-guided focused ultrasound.
    Wang F; Shi Y; Lu L; Liu L; Cai Y; Zheng H; Liu X; Yan F; Zou C; Sun C; Shi J; Lu S; Chen Y
    PLoS One; 2012; 7(12):e52925. PubMed ID: 23300823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Different Microbubbles in Assisting Focused Ultrasound-Induced Blood-Brain Barrier Opening.
    Wu SK; Chu PC; Chai WY; Kang ST; Tsai CH; Fan CH; Yeh CK; Liu HL
    Sci Rep; 2017 Apr; 7():46689. PubMed ID: 28425493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.
    McBride JL; During MJ; Wuu J; Chen EY; Leurgans SE; Kordower JH
    Exp Neurol; 2003 Jun; 181(2):213-23. PubMed ID: 12781994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focused Ultrasound-Mediated Disruption of the Blood-Brain Barrier for AAV9 Delivery in a Mouse Model of Huntington's Disease.
    Owusu-Yaw BS; Zhang Y; Garrett L; Yao A; Shing K; Batista AR; Sena-Esteves M; Upadhyay J; Kegel-Gleason K; Todd N
    Pharmaceutics; 2024 May; 16(6):. PubMed ID: 38931834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focused ultrasound-mediated noninvasive blood-brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters.
    Shin J; Kong C; Cho JS; Lee J; Koh CS; Yoon MS; Na YC; Chang WS; Chang JW
    Neurosurg Focus; 2018 Feb; 44(2):E15. PubMed ID: 29385915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophins as Therapeutic Agents for Parkinson's Disease; New Chances From Focused Ultrasound?
    Stefani A; Pierantozzi M; Cardarelli S; Stefani L; Cerroni R; Conti M; Garasto E; Mercuri NB; Marini C; Sucapane P
    Front Neurosci; 2022; 16():846681. PubMed ID: 35401084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes.
    Popovic N; Maingay M; Kirik D; Brundin P
    Exp Neurol; 2005 May; 193(1):65-74. PubMed ID: 15817265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.
    Harper SQ; Staber PD; He X; Eliason SL; Martins IH; Mao Q; Yang L; Kotin RM; Paulson HL; Davidson BL
    Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5820-5. PubMed ID: 15811941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculotide restores the blood-brain barrier after focused ultrasound-induced permeability in a mouse model of Alzheimer's disease.
    Lynch M; Heinen S; Markham-Coultes K; O'Reilly M; Van Slyke P; Dumont DJ; Hynynen K; Aubert I
    Int J Med Sci; 2021; 18(2):482-493. PubMed ID: 33390817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model.
    Mead BP; Kim N; Miller GW; Hodges D; Mastorakos P; Klibanov AL; Mandell JW; Hirsh J; Suk JS; Hanes J; Price RJ
    Nano Lett; 2017 Jun; 17(6):3533-3542. PubMed ID: 28511006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of Liposomes with Different Sizes to Mice Brain after Sonication by Focused Ultrasound in the Presence of Microbubbles.
    Shen Y; Guo J; Chen G; Chin CT; Chen X; Chen J; Wang F; Chen S; Dan G
    Ultrasound Med Biol; 2016 Jul; 42(7):1499-511. PubMed ID: 27126236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments.
    Poon C; Pellow C; Hynynen K
    Theranostics; 2021; 11(4):1655-1671. PubMed ID: 33408773
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic efficacy of regulable GDNF expression for Huntington's and Parkinson's disease by a high-induction, background-free "GeneSwitch" vector.
    Cheng S; Tereshchenko J; Zimmer V; Vachey G; Pythoud C; Rey M; Liefhebber J; Raina A; Streit F; Mazur A; Bähr M; Konstantinova P; Déglon N; Kügler S
    Exp Neurol; 2018 Nov; 309():79-90. PubMed ID: 30076831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.